Core Insights - The avian influenza concept sector saw a significant increase of 6.89%, leading the market in terms of growth, with 25 stocks rising, including notable gains from Zhijiang Biology and Hualan Biological at 20% limit up [1][2]. Market Performance - The avian influenza sector was the top performer today, with a 6.89% increase, while other sectors like military information technology and metal lead experienced declines of -4.70% and -4.42% respectively [2]. - The avian influenza sector attracted a net inflow of 1.239 billion yuan, with 20 stocks receiving significant capital inflows, and five stocks exceeding 100 million yuan in net inflow [2]. Key Stocks and Capital Inflows - Leading stocks in the avian influenza sector included: - Zhongsheng Pharmaceutical with a net inflow of 222.94 million yuan and a 6.50% increase [3]. - Daan Gene with a 10.05% increase and a net inflow of 164.66 million yuan, representing a net inflow rate of 46.21% [3]. - Hualan Biological, which saw a 20% increase and a net inflow of 143.34 million yuan, with a net inflow rate of 23.86% [3]. - Other notable stocks included Yiling Pharmaceutical and Rhine Biology, with respective increases of 7.90% and 9.05% [3][4].
12.39亿主力资金净流入,禽流感概念涨6.89%